EcoDrugPlus

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSOTSG00005031575
Gene Symbol: LOC112248680
3 Cross references
205 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSOTSG00005021305
Gene Symbol: LOXL2A
1 Cross references
204 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSOTSG00005040434
Gene Symbol: LOXL2B
1 Cross references
205 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSOTSG00005040921
Gene Symbol: LOXL2B
1 Cross references
205 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSOTSG00005022412
Gene Symbol: MIF
1 Cross references
221 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSOTSG00005031038
Gene Symbol: LOC112256110
3 Cross references
221 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSOTSG00005045214
Gene Symbol: MST1R
3 Cross references
187 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSOTSG00005033348
Gene Symbol: MST1R
1 Cross references
180 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSOTSG00005041314
Gene Symbol: MST1R
3 Cross references
180 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSOTSG00005030351
Gene Symbol: MST1R
3 Cross references
187 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSOTSG00005034462
Gene Symbol: LOC112220969
2 Cross references
180 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSOTSG00005034086
Gene Symbol: LOC112220969
2 Cross references
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).